Global Interventional Cardiology Devices Market Projected to Reach $21.9 Billion by 2030
April 08, 2024 04:02 ET
|
Research and Markets
Dublin, April 08, 2024 (GLOBE NEWSWIRE) -- The "Global Interventional Cardiology Devices Market Size, Share & Industry Trends Analysis Report By End-use (Hospitals & Clinics, Ambulatory...
Global Leadless Pacemakers Market Projected to Surpass $827.7 Million by 2030 with Notable Industry Advancements
April 04, 2024 11:45 ET
|
Research and Markets
Dublin, April 04, 2024 (GLOBE NEWSWIRE) -- The "Global Leadless Pacemakers Market Size, Share & Industry Trends Analysis Report By Type (Micra Transcatheter Pacing System, and Others), By...
BioSig Announces Reduction of its Workforce
February 20, 2024 10:00 ET
|
BioSig Technologies, Inc.
Westport, CT, Feb. 20, 2024 (GLOBE NEWSWIRE) -- -- BioSig Technologies, Inc. (NASDAQ: BSGM) ("BioSig" or the "Company"), a medical technology company, today announced that it has terminated a...
BioSig’s PURE EP™ Platform with New Near Field Tracking Algorithm Surpasses 100 Patient Cases
February 06, 2024 08:30 ET
|
BioSig Technologies, Inc.
Westport, CT, Feb. 06, 2024 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical technology company committed to delivering unprecedented accuracy and...
Active Implantable Medical Devices Market Set to Surge to US$45.686 Billion by 2028 Amid Advances in Technology and Aging Population Needs
February 05, 2024 04:03 ET
|
Research and Markets
Dublin, Feb. 05, 2024 (GLOBE NEWSWIRE) -- The "Active Implantable Medical Devices (AIMD) Market - Forecasts from 2023 to 2028" report has been added to ResearchAndMarkets.com's offering. This...
BioSig Announces Reverse Stock Split
January 31, 2024 11:15 ET
|
BioSig Technologies, Inc.
Westport, CT, Jan. 31, 2024 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) ("BioSig" or the "Company"), a medical technology company committed to delivering unprecedented accuracy and...
BioSig Announces Cost Reductions to Improve its Financial Standing and Shifts its Core Strategy
January 30, 2024 08:30 ET
|
BioSig Technologies, Inc.
Cost Savings Targeted to Reduce Cash Burn by 50% Core Strategy Shifts to Business Development and Distribution Partnerships Westport, CT, Jan. 30, 2024 (GLOBE NEWSWIRE) -- BioSig...
Cardiac Mapping Market Projected to Reach USD 6.98 Billion by 2034, Driven by Technological Advances and Growing Cardiac Disease Prevalence
January 30, 2024 06:05 ET
|
Research and Markets
Dublin, Jan. 30, 2024 (GLOBE NEWSWIRE) -- The "Global Cardiac Mapping Market Analysis & Forecast to 2024-2034" report has been added to ResearchAndMarkets.com's offering. The global landscape...
BioSig Issues Letter to Shareholders Detailing Technology Innovations and Strategic Focus for 2024
December 06, 2023 14:20 ET
|
BioSig Technologies, Inc.
Westport, CT, Dec. 06, 2023 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (Nasdaq: BSGM) (“BioSig” or the “Company”), a medical technology company delivering unprecedented accuracy and precision to...
Baptist Health Lexington Enhances 20-Year Leadership in Pioneering Advanced Robotic Technology for Heart Disease Patients
November 28, 2023 08:42 ET
|
Stereotaxis, Inc.
Baptist Health Lexington has become one of the first in the world to provide the latest in robotic technology to treat arrhythmias